Neuronetics (STIM) Equity Ratio (2017 - 2025)
Historic Equity Ratio for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to 0.22.
- Neuronetics' Equity Ratio rose 7032.81% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 7032.81%. This contributed to the annual value of 0.23 for FY2024, which is 2354.27% down from last year.
- Neuronetics' Equity Ratio amounted to 0.22 in Q3 2025, which was up 7032.81% from 0.23 recorded in Q2 2025.
- In the past 5 years, Neuronetics' Equity Ratio ranged from a high of 0.67 in Q1 2021 and a low of 0.13 during Q3 2024
- In the last 5 years, Neuronetics' Equity Ratio had a median value of 0.45 in 2023 and averaged 0.42.
- In the last 5 years, Neuronetics' Equity Ratio skyrocketed by 8609.0% in 2021 and then tumbled by 6897.95% in 2024.
- Neuronetics' Equity Ratio (Quarter) stood at 0.6 in 2021, then decreased by 19.06% to 0.49 in 2022, then crashed by 39.54% to 0.3 in 2023, then fell by 23.54% to 0.23 in 2024, then fell by 4.47% to 0.22 in 2025.
- Its Equity Ratio stands at 0.22 for Q3 2025, versus 0.23 for Q2 2025 and 0.28 for Q1 2025.